WASHINGTON (AP) — After months of criticism over its recently launched painkiller Zohydro, the maker of the powerful narcotic is highlighting an unusual oversight board that it’s assembled to try and prevent abuse of the drug.

Zogenix’s president and director, Stephen Farr, told the Associated Press that the outside group of seven medical, addiction and law enforcement specialists will be able to spot early signs of misuse using data from sources that include prescribing statistics, addiction center reports and law enforcement records.